相关实验视频
Updated: Oct 31, 2025

10:34
Ligand Nano-cluster Arrays in a Supported Lipid Bilayer
Published on: April 23, 2017
7.1K
体功能化DNA纳米结构与细胞相互作用的决定因素
Glenn A O Cremers1,2, Bas J H M Rosier1,2, Ab Meijs1,2,3
1Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB Eindhoven, The Netherlands.
Journal of the American Chemical Society
|June 28, 2021
概括
用抗体功能化的DNA纳米结构提供有针对性的药物输送. 纳米结构的大小和DNA手柄位置显著影响细胞表面受体的结合效率,指导最佳的纳米医学设计.
科学领域:
- 生物技术
- 纳米技术
- 分子生物学
背景情况:
- 带功能化纳米材料对于向的纳米药物至关重要.
- 通过DNA纳米技术,可以精确地构建纳米结构以进行受控的连接.
- 了解细胞可访问性是有效向细胞表面受体的关键.
研究的目的:
- 研究影响抗体功能化DNA纳米结构与细胞表面受体的设计参数.
- 确定调节受体可访问性和结合效率的结构决定因素.
- 用DNA纳米结构优化细胞向的设计规则.
主要方法:
- 对抗体功能化DNA纳米结构的系统研究.
- 对特定受体的结合评估:编程细胞死亡蛋白1 (PD-1),表皮生长因子受体 (EGFR) 和人体表皮生长因子受体2 (HER2).
- 分析纳米结构大小和DNA手柄位置作为关键设计参数.
主要成果:
- 与可溶性抗体相比,原生抗体亲和力保持不变,但由于可访问性限制,总体受体结合性降低.
- 纳米结构的大小和DNA手柄的位置决定了受体结合效率.
- 获得了对受体结合机制的洞察,突出显示了纳米结构架构的影响.
结论:
- 抗体功能化的DNA纳米结构可以结合细胞表面受体,但效率受到可访问性的影响.
- 纳米结构的大小和DNA手柄的位置是优化细胞向的关键设计因素.
- 这项研究为开发有效的联体功能化DNA纳米结构提供了基本的设计规则.
相关概念视频
Ligand Binding Sites
14.3K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.3K
Metal-Ligand Bonds
22.5K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
22.5K
Drug-Receptor Bonds
3.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.7K
Labeling DNA Probes
8.6K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
8.6K
Ligand Binding and Linkage
5.1K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.1K

